ImageneBio appoints Yanina Grant-Huerta as CFO; CMO Benjamin Porter-Brown transitions to consulting role

ImageneBio, Inc.

Yanina Grant-Huerta appointed CFO effective July 20, 2026; base salary $450,000, target bonus 40%, equity grants of 65,000 RSUs and 95,000 options.
Benjamin Porter-Brown, CMO, will transition from full-time to consulting role effective July 24, 2026; will serve as strategic advisor.
Grant-Huerta previously served as Chief Accounting Officer at Atara Biotherapeutics (ATRA) from March 2025 to July 2026.
Grant-Huerta's equity awards vest over four years; 25% on first anniversary, remainder monthly/quarterly.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Yanina Grant-Huerta

Chief Financial Officer

IMA · ImageneBio, Inc.

Effective: 2026-07-20
Filed: July 23, 2026, 4:25 PM ET

On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective July 20, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Yanina Grant-Huerta was appointed as Chief Financial Officer at ImageneBio, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 20, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), based in part on the recommendation of Kristin Yarema, Ph.D., the Company’s Chief Executive Officer, appointed Yanina Grant-Huerta as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective July 20, 2026.

View on SEC.gov

ImageneBio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-314167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.